Trials / Completed
CompletedNCT01881633
A Study of the Tolerability, Safety, and Pharmacokinetics of ISU302 in Healthy Volunteers
A Dose Block-randomized, Double-blind, Placebo-controlled, Single Dosing, Dose-escalation Phase I Clinical Trial to Evaluate the Tolerability, Safety, and Pharmacokinetics of ISU302 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- ISU Abxis Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of single dosing study with three ascending dose cohorts of ISU302 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ISU302 | |
| DRUG | Placebo |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2013-06-19
- Last updated
- 2013-06-19
Source: ClinicalTrials.gov record NCT01881633. Inclusion in this directory is not an endorsement.